MAPT and Alzheimer disease: NPT088 was suggested to bind to α-Syn, amyloid-beta, and tau aggregates (The latter two are implicated in Alzheimer’s disease (AD) and frontotemporal dementia), reducing the deposition of proteinase K-resistant proteins [50].